Skip to main content
. Author manuscript; available in PMC: 2011 Mar 15.
Published in final edited form as: Cancer. 2010 Mar 15;116(6):1476–1484. doi: 10.1002/cncr.24861

Table V.

Toxicity

Toxicity Grade 1(%) Grade 2 (%) Grade 3 (%) Grade 4 (%)

Alopecia 4 (6) 48 (77) 0 0

Allergic Reaction 2 (3) 1 (1) 0 0

Anorexia 27 (44) 11 (17) 0 0

Arthralgia/myalgia 19 (31) 12 (19) 0 0

Bone pain 29 (47) 12 (19) 0 0

Constipation 14 (23) 5 (8) 1 (1) 0

Dehydration/IV fluids 5 (8) 1 (1) 0 0

Depression 10 (16) 8 (13) 0 0

Diarrhea 18 (29) 15 (24) 8 (13) 0

Dizziness 30 (48) 2 (3) 0 0

Fatigue 19 (31) 23 (37) 8 (13) 0

Fever 11 (17) 12 (19) 2 (3) 0

Edema 15 (24) 3 (5) 0 0

Headache 15 (24) 2 (3) 0 0

Hypotension 1 (1) 3 (5) 0 0

Hematologic
 Neutropenia 1 (1) 2 (3) 17 (27)* 5 (8)*
 Neutropenic fever 0 0 17 (27) 5 (8)
 Thrombocytopenia 12 (26) 18 (39) 16 (35) 0

Laboratory
Abnormalities** 0 26 (46) 20 (43) 0
 Anemia 33 (72) 3 (6) 6 (13) 0
 Hypomagnesemia 0 1 (2) 0 0
 Elevated creatinine 21 (46) 5 (11) 2 (4) 2 (4)
 Transaminitis 0 2 (4) 0 1 (2)***
 Hyperbilirubinemia

Mucositis 17 (27) 5 (8) 0 0

Nausea 26 (42) 17 (27) 3 (5) 1 (1)

Neuropathy 23 (37) 19 (31) 12 (19) 0

Rash 7 (11) 1 (1) 0 0

Tinnitus 2 (3) 3 (5) 0 0

Vomiting 24 (39) 11 (17) 5 (8) 1 (1)

Weight Loss 3 (5) 2 (3) 1 (1) 0
*

does not include patients with neutropenic fever

**

NCI cohort, n=46

***

Gilbert’s syndrome